Quick Answer: An ASEAN cosmetic Product Information File (PIF) holds the evidence behind a product’s composition, quality, safety and claims. The recommended structure has four parts: administrative documents and product summary; raw material quality; finished product quality; and safety and efficacy. Arrange access through the company placing the product on each local market. Notification is a separate procedure and does not replace the file.
A useful PIF is a working evidence system. A folder full of certificates can still leave basic questions unanswered: which formula was assessed, which artwork was sold, and who can retrieve the supporting report? Brand owners should settle these questions before approving production. The file needs a clear product identity and a dependable route from its summary to the underlying evidence.
This guide combines the official regional framework with practical project controls for a brand buying from an OEM/ODM cosmetics manufacturer. The workflow suggestions are planning tools. National implementation and the circumstances of the product determine what the local company must actually maintain and produce.
Separate the PIF from cosmetic notification
The ASEAN Cosmetic Directive addresses product information, safety and responsibility within the harmonized scheme. A PIF supports the product throughout its market life. Notification records a market procedure. Treat them as linked records with different purposes rather than assuming that completion of one proves completion of the other.
Build the relevant notification administrative record into your file, while independently checking whether the technical evidence is complete. Confirm submission and subsequent change procedures with the destination authority. Our ASEAN notification guide explains the separate market handoffs.
For example, a launch spreadsheet might show that the local submission is complete while the manufacturing team is still resolving a revised bottle specification. That should remain an open technical issue, with an owner and a release decision. A completed submission must not make the packaging evidence disappear from the project checklist.
Use the recommended four-part structure
The official ASEAN PIF guideline linked by HSA recommends four parts and a contents list for each. It distinguishes the recommended organization from the underlying information obligations. Use the structure to make review easier; do not describe the guideline itself as a new regional approval certificate.
| Part | Purpose | Useful navigation control |
|---|---|---|
| I — Administrative Documents and Product Summary | Identify the product, presentation, parties and key summaries | A product-specific index pointing to current supporting records |
| II — Quality Data of Raw Materials | Organize ingredient specifications, methods and relevant safety information | A supplier and raw material revision register |
| III — Quality Data of Finished Product | Connect the formula, manufacture, finished specifications and stability evidence | A formula and finished product revision map |
| IV — Safety and Efficacy Data | Hold the safety assessment, undesirable effects record and claims support | An assessment and claim-to-evidence register |
Start with a single controlled product code. Add the market name, commercial name and any variant identifiers to the index. A distributor may use a different selling name from the factory’s development name; record that relationship explicitly. It saves reviewers from guessing whether a report for a laboratory code applies to the product in their hands.
Give every index entry a document owner, revision, approval date and storage location. Mark a genuine gap as pending rather than inserting an unrelated report to make a checklist look complete. If a document is not applicable, ask the reviewer to record a reason. These small controls make the file more useful than a large unsorted email archive.
Build a product summary that leads to evidence
Use Part I as the reader’s starting point. Present the identity and presentation of the product clearly, with the relevant administrative evidence and concise technical summaries. The detailed regional guideline identifies formula, labelling, manufacturing, safety and claims information within this overview. Keep the summary aligned with the technical sections rather than editing it independently.
A practical approach is to attach the approved artwork revision and identify the formula revision on the same release sheet. If the carton changes, the release sheet should explain whether the change is purely visual or affects directions, warnings, claims or another reviewed feature. A new print date alone does not explain the significance of the change.
Ask a colleague who did not assemble the file to locate the current product name, manufacturer, label and assessment reference. If they need the original compiler to interpret filenames, improve the navigation before the handoff. This retrieval exercise is especially helpful when several brands share a factory platform but sell different presentations.
Connect raw material quality to the finished product
A manufacturer’s document package should let the reviewer follow a material from supplier identity to formula use. Agree how trade names, ingredient names and blend identifiers will be reconciled. For a confidential mixture, establish an appropriate disclosure arrangement with the technical reviewer. An unresolved identity question should have an owner and a deadline within the project, rather than an assumption that another party has checked it.
The finished product section should tell the same story as the production release. Compare the report identifiers with the selected formula, manufacturing location, packaging and intended presentation. Read across the records: a test report may be authentic yet concern a different revision. Review the scope of each document before relying on its conclusion.
Ingredient compliance also needs its own current review. Use our ASEAN ingredient restrictions guide to plan the identity and annex check. Keep its conclusion linked to the formula reviewed. A purchasing substitution should trigger a documented question about the affected evidence before the substitute enters a commercial batch.
Keep the safety assessment and claim support specific
Part IV is where a reviewer should find the reasoning behind the product’s safety and benefits. In Malaysia, NPRA’s PIF guideline, Annex I Part 13, describes a signed finished-product safety assessment, assessor qualifications, updated undesirable-effect information and relevant efficacy evidence. Review the national document when compiling the local file.
For project control, create a row for every planned claim and point it to the exact supporting material. Include the wording and placement: a short carton claim and a longer online claim can communicate different promises. Have the brand and technical reviewer agree the final wording before sending the artwork to print. If the evidence supports a narrower benefit, revise the claim or obtain suitable additional support.
Do not rename an EU Cosmetic Product Safety Report and assume it completes the ASEAN file. Existing international evidence can be assessed for relevance, but the local reviewer needs to determine whether it addresses the actual product and destination requirements. The ASEAN structure and the EU report format are different frameworks. Record any gap analysis and the additional work needed.
| Scope | Official starting point | Project action |
|---|---|---|
| ASEAN regional framework | ACD and recommended PIF organization | Use the four-part index and map the underlying evidence |
| Malaysia | NPRA Annex I Part 13 | Confirm the CNH access arrangement and national file expectations |
| Other destination markets | Current national authority requirements | Check local responsibility, access and procedures before release |
Arrange local availability and confidential access
The regional guideline ties authority access to the company placing the product on the local market and the address shown on the label. Malaysia’s guideline assigns accessibility to the Cosmetic Notification Holder (CNH). A factory-held master folder is therefore only one part of the arrangement: the local company needs a workable access process.
Make that process concrete. Name a primary contact and a backup, agree where the current index is stored, and test whether the local contact can retrieve the reviewed summary. For confidential technical documents, agree who sends them to the authority and how receipt will be confirmed. The agreement should remain usable during staff changes or a commercial dispute.
Do not copy a retention recommendation or audit example into a universal ASEAN deadline. The regional and Malaysian guidelines discuss retention and audit access, including urgent situations. Confirm the current destination expectations and any authority request. A commercial response target can help the team work, but it should be labelled as an internal service target rather than a statutory entitlement to delay.
Allocate responsibilities before the manufacturing order
The brand should define the intended product and claims; the manufacturer should supply controlled technical evidence within the agreed scope; and the local responsible company should confirm destination procedures and authority access. Put these deliverables into the project agreement. A general promise to supply a compliance folder rarely explains who pays for a missing study or who obtains a confidential supplier document.
| Workstream | Lead to agree | Completion evidence |
|---|---|---|
| Technical composition and manufacture | Manufacturer with relevant suppliers | Controlled documents mapped to the product revision |
| Positioning, claims and artwork | Brand owner with technical reviewer | Approved claims and final artwork |
| Safety and evidence applicability | Suitably qualified assessor or reviewer | Signed review and closed questions |
| Local file access and procedure | Local responsible company or CNH, as applicable | Market index, access contacts and national checks |
| Change management and complaints | Brand, manufacturer and local company | Impact decision linked to affected batches and records |
Before requesting a quotation, list what evidence already exists and what is still needed. Identify whether the order uses an existing formula, a modified base or a new development. Ask which documents can be shared with the brand and which require direct confidential access. Use the project contact page with a clear product brief and target markets so the document scope can be discussed alongside manufacturing.
Maintain the file after launch
Keep a change log that records the trigger, affected documents, reviewer and decision. Useful triggers include a new supplier, formula revision, packaging change, changed directions, new market or revised claim. Link the approved change to the batches it affects. Keep historical revisions retrievable so an enquiry about an earlier batch can be answered accurately.
Schedule a file review as part of ordinary product maintenance. Check contacts, access permissions and broken document links as well as technical content. A technically complete file can become unusable when an employee leaves or a shared folder is reorganized. Confirm the local company’s access again when distribution arrangements change.
Frequently asked questions
What are the four parts of an ASEAN cosmetic PIF?
The recommended parts cover administrative documents and product summary, raw material quality, finished product quality, and safety and efficacy data. Use an index to connect each part to the relevant current records.
Does cosmetic notification replace the PIF?
No. Manage the notification procedure and technical file separately, cross-referencing their administrative records. Completion of a submission does not resolve an outstanding technical evidence question.
Can the manufacturer keep every document overseas?
A factory can support the master technical records, but the company placing the product locally must have the access arrangement required for its destination. Confirm local availability and any confidential authority disclosure route.
Is an EU safety report automatically sufficient?
No. Ask the qualified reviewer to assess its relevance to the actual formula, presentation, use and destination. Record missing information and additional work rather than treating a document title as proof of completeness.
How long does compilation take?
There is no useful universal lead time. Estimate the work after checking existing documents, missing studies, confidentiality arrangements and review capacity. Agree project milestones and check destination timing separately.
Last reviewed: 21 October 2026. This guide provides general planning information, not a product-specific legal or safety determination. Verify current official national requirements and seek qualified advice before notification, manufacture, import or sale.